Tag: WuXi Biologics
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.Â
Featured Article
Behind the Australian Made logo: Six manufacturers shaping local industry
Australian manufacturers are continuing to invest in local production, innovation and sustainability across a wide range of industries. From textiles and packaging to construction and advanced manufacturing, Australian Made licensees are developing products tailored to local conditions while supporting Australian jobs and capabilities.
